# Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System

Study · id `cardio:ct-nct01788150` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01788150](<https://clinicaltrials.gov/study/NCT01788150>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01788150

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.

## Technical summary

Registry record NCT01788150. Randomized; no masking; primary purpose treatment. Start 2013-01 (actual); primary completion 2014-05 (actual). Results posted on 2021-05-04.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 159 participants (enrolled count; ClinicalTrials.gov record NCT01788150, source copy `cardio:ctgov-nct01788150-2021-05-04`, retrieved 2026-10-26)
- Started: 2013-01 (actual) (ClinicalTrials.gov record NCT01788150, source copy `cardio:ctgov-nct01788150-2021-05-04`, retrieved 2026-10-26)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01788150, source copy `cardio:ctgov-nct01788150-2021-05-04`, retrieved 2026-10-26)
- Completion: 2019-05-31 (actual) (ClinicalTrials.gov record NCT01788150, source copy `cardio:ctgov-nct01788150-2021-05-04`, retrieved 2026-10-26)
- Results first posted: 2021-05-04 (ClinicalTrials.gov record NCT01788150, source copy `cardio:ctgov-nct01788150-2021-05-04`, retrieved 2026-10-26)
- Countries: Belgium; Czechia; France; Germany; Netherlands; Sweden; Switzerland (ClinicalTrials.gov record NCT01788150, source copy `cardio:ctgov-nct01788150-2021-05-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01788150-2021-05-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System
- Acronym: DIRECT II
- Condition: Coronary Artery Disease
- Intervention (Device): Coronary Stenting
- Lead sponsor: Svelte Medical Systems, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: edafc011fb8360ab01f1db15d4979a2495bd223c4ab509e25c32bfd1c5ad71ac
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
